September 10, 2025International Journal of Research in Medical SciencesOpen Access

Psoriasis and metabolic dysfunction-associated steatotic liver disease: an underestimated connection: a case report

View Full Paper

Ask AI

Bookmark

Authors

MRMaría D. L. C. Rodríguez-Suárez CSCésar A. Santoyo-Reza CMCarlos Márquez-Alvarado

Discussion

Member takes

Implication

Case report highlights psoriasis' impact on metabolic dysfunction-associated steatotic liver disease, suggesting early intervention may improve outcomes.

Key Points

Connects psoriasis with metabolic dysfunction-associated steatotic liver disease, revealing a common inflammatory pathway.
Patient with both type 2 diabetes and psoriasis showed liver steatosis and fibrosis, indicating severe comorbid risks.
Treatment was complex due to the coexistence of liver disease, requiring careful management of pharmaceuticals.
Emphasizes the need for early liver ultrasound in psoriatic patients to guide treatment decisions and mitigate risks.

Cite This Study

Rodríguez-Suárez et al. (2025) studied this question.

synapsesocial.com/papers/68c243f6b210217d647a8fee https://doi.org/10.18203/2320-6012.ijrms20252801

View Full Paper

Ask AI

Bookmark

Implication

Case report highlights psoriasis' impact on metabolic dysfunction-associated steatotic liver disease, suggesting early intervention may improve outcomes.

Psoriasis and metabolic dysfunction-associated steatotic liver disease: an underestimated connection: a case report

Discussion

Member takes

Implication

Key Points

Cite This Study

Psoriasis and metabolic dysfunction-associated steatotic liver disease: an underestimated connection: a case report

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider